United States Diagnostics & Research news

06:03 30 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies Corp (ADPT) (Q2 2026) Earnings Call Highlights: MRD Revenue Surges ...

This article first appeared on GuruFocus. Total Revenue: $71.6 million, up 30% year-over-year. MRD Revenue: $66.2 million, up 33% year-over-year; core MRD revenue (excluding milestones) grew 49%. Clinical Revenue (MRD): Increased 53% year-over-year, driven by a 43% increase in testing volumes and a 7% …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

05:48 30 Jul 2026

TradingKey Regulatory and legal Provider-linked mention 🇺🇸 United States

ARVN|Arvinas Inc|Price:8.230|Chg%:+0.030

This article provides a comprehensive stock analysis of Arvinas Inc (ARVN), highlighting its healthy fundamentals, significant growth potential, and "fairly valued" status. It notes high institutional ownership and multiple "Buy" ratings from analysts, despite a medium-term expectation for the stock price to trend down …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

05:40 30 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

MDxHealth SA Revenue Breakdown – NASDAQ:MDXH

MDxHealth SA (NASDAQ: MDXH) generated $107.88 million USD in revenue last year, primarily from its Tissue-based segment, which contributed $81.49 million USD. The majority of its revenue, $107.88 million USD, originated from the United States, Europe, and the Rest of the World.

MDXH main company

Sharemaestro market context Price below Trend Line 52 weeks -75.4% · Next-week setup negative 39.0%

05:11 30 Jul 2026

Stock Traders Daily Market update Main company 🇺🇸 United States

Behavioral Patterns of FLGT and Institutional Flows

This article analyzes behavioral patterns and institutional flows for Fulgent Genetics Inc. (NASDAQ: FLGT), suggesting a near-term neutral sentiment that may pause mid- and long-term weakness. It highlights an exceptional 96.0:1 risk-reward setup targeting a 26.9% gain with minimal risk. The report also provides …

FLGT main company

Sharemaestro market context Price above Trend Line 52 weeks -14.7% · Next-week setup negative 42.1%

05:10 30 Jul 2026

Simply Wall St Earnings Main company 🇺🇸 United States

Medpace Holdings (MEDP) Is Up 10.8% After Boosting 2026 Outlook And Retiring 17% Of Shares - Has The Bull Case Changed?

Medpace Holdings (MEDP) saw a 10.8% stock increase after reporting strong Q2 2026 results, boosting its 2026 outlook, and completing a significant share repurchase program that retired 17.25% of its shares. The company now projects 2026 revenue between US$2.81 billion and US$2.89 billion, with …

MEDP main company

Sharemaestro market context Trend signal active 52 weeks +24.8% · Next-week setup positive 59.0%

05:09 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

PGNY|Progyny Inc|Price:31.360|Chg%:+0.600

This article from TradingKey provides a comprehensive stock analysis of Progyny Inc (PGNY), highlighting its strong fundamentals, high growth potential, and "Buy" rating from analysts. It notes that the company is fairly valued with high institutional ownership, although its technical performance doesn't fully support …

DGX mentioned LH mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

05:01 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Labcorp Holdings Inc stock hits 52-week high at 315.82 USD

Labcorp Holdings Inc (LH) stock has reached a new 52-week high of $315.82, following a 20.83% increase over the past year and 23% year-to-date returns. The company recently reported strong Q2 results, with adjusted earnings of $4.99 per share and revenue of $3.73 billion, …

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

04:40 30 Jul 2026

Investing.com Nigeria Earnings Main company 🇺🇸 United States

ICON PLC earnings beat by $0.01, revenue topped estimates

ICON PLC reported second-quarter earnings per share (EPS) of $2.56, surpassing analyst estimates by $0.01. The company's revenue for the quarter reached $2.06 billion, exceeding the consensus estimate of $2 billion. ICON PLC's stock price has increased by 57.50% in the last three months, …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

04:40 30 Jul 2026

Revelio Labs Earnings Main company 🇺🇸 United States

QIAGEN Number of Employees 2026 | Employee Count & Headcount Data

QIAGEN NV (QGEN) has approximately 5,617 employees worldwide as of March 2026, marking a 6.6% decline from 2023. The company is actively hiring, with 272 job postings in 2026, though new postings per month have decreased. The workforce is primarily concentrated in the United …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.1%

04:39 30 Jul 2026

BioSpace Earnings Main company 🇺🇸 United States

ICON Reports Second Quarter 2026 Results

ICON plc reported its financial results for the second quarter ended June 30, 2026, with revenue reaching $2,063.5 million and adjusted diluted earnings per share of $2.56. The company reaffirmed its full-year 2026 financial guidance, anticipating revenue between $7,850 and $8,150 million, and adjusted …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

04:27 30 Jul 2026

Timothy Sykes Earnings Main company 🇺🇸 United States

IQVIA Holdings Inc. (IQV) Stock Price | Live Quotes & Charts | NYSE

This page provides live quotes and charts for IQVIA Holdings Inc. (IQV) stock on the NYSE. It shows a current stock price of $247.56, up $4.62 (1.90%), but notes that prices are delayed. The article also mentions the absence of analyst ratings and earnings …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

04:20 30 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $248.86, Implies 6% Upside

The average 12-month price target for Quest Diagnostics Incorporated (DGX) stock has been raised by analysts from $246.6 to $248.86, indicating an approximate 6% potential upside from its July 29th closing price. The consensus rating from 20 analysts remains a "Buy," with 9 Buys, …

DGX main company

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

04:09 30 Jul 2026

Revelio Labs Earnings Main company 🇺🇸 United States

OPKO Health Number of Employees 2026 | Employee Count & Headcount Data

OPKO Health (NASDAQ: OPK) had approximately 2,275 employees worldwide as of March 2026, representing a 13.9% decline from 2023. Despite this decline, the company is actively hiring, with 129 active job postings in 2026, a 71.6% increase from the previous year. The workforce is …

OPK main company

Sharemaestro market context Trend signal active 52 weeks -2.1%

04:04 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

ALXO|ALX Oncology Holdings Inc|Price:1.950|Chg%:-0.040

This article provides a comprehensive stock analysis of ALX Oncology Holdings Inc (ALXO), highlighting its relatively weak fundamentals but high growth potential and fair valuation within the Biotechnology & Medical Research industry. The company's lead product candidate, evorpacept, is a CD47 blocking therapeutic, and …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

03:41 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

PAR|PAR Technology Corp|Price:16.560|Chg%:-0.800

This article provides a comprehensive stock analysis of PAR Technology Corp (PAR), highlighting its strong fundamentals, high growth potential, and "fairly valued" status. Despite recent weak market performance, the company shows solid growth in revenue and net income. Analysts currently rate PAR as a …

MTD mentioned

Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4%

03:39 30 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Adaptive Biotechnologies Corp (ADPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Adaptive Biotechnologies Corp (AD

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

03:39 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

VSTM|Verastem Inc|Price:6.013|Chg%:-0.217

This article provides a comprehensive stock analysis of Verastem Inc (VSTM) by TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. The company's stock is rated "Buy" by multiple analysts with a target price …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

03:13 30 Jul 2026

TradingKey Regulatory and legal Provider-linked mention 🇺🇸 United States

RCUS|Arcus Biosciences Inc|Price:26.470|Chg%:-0.580

This article provides a comprehensive stock analysis of Arcus Biosciences Inc (RCUS) by TradingKey, highlighting its stable fundamentals, significant growth potential, and a "fairly valued" rating within the Biotechnology & Medical Research industry. The company, a clinical-stage biopharmaceutical firm focused on cancer therapies, shows …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

03:13 30 Jul 2026

Mugglehead Investment Magazine Deals and strategy Provider-linked mention 🇺🇸 United States

Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform

Tempus AI is acquiring Personalis in a $1.5 billion deal to expand its AI-driven cancer monitoring platform. The acquisition will integrate Personalis' NeXT Personal tumor-informed liquid biopsy platform with Tempus' clinical data ecosystem to enhance cancer detection and personalized treatment. This move targets the …

PSNL mentioned

Sharemaestro market context Trend signal active 52 weeks +190.7%

02:41 30 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Insider at Natera, Inc. (NTRA) sells shares to cover RSU tax obligations

Natera, Inc.'s Secretary and Chief Legal Officer, Daniel Rabinowitz, sold a total of 1,887 shares of common stock on July 27-28, 2026. These sales, valued at approximately $485,000, were executed to cover tax withholding obligations stemming from the vesting of Restricted Stock Units (RSUs). …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

02:41 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Natera CFO Michael Brophy sells $1.28 million of company stock

Natera CFO Michael Brophy sold 5,064 shares of company stock worth $1.28 million between July 27 and July 29, 2026. These sales were primarily to satisfy tax withholding obligations related to vested Restricted Stock Units and some were conducted under a Rule 10b5-1 trading …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

02:41 30 Jul 2026

Investing.com Earnings Main company 🇺🇸 United States

Natera president Moshkevich sells $568,996 in shares

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold shares worth $568,996 across two days in late July 2026. These sales were primarily conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units and were made under a pre-arranged …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

02:41 30 Jul 2026

Stock Titan Earnings Main company 🇺🇸 United States

Natera, Inc. (NTRA) CEO trades 5,770 shares under Rule 10b5-1 plan

Steven Leonard Chapman, CEO and President of Natera, Inc. (NTRA), sold 5,770 shares of common stock on July 27–28, 2026, to cover tax withholding and remittance obligations related to the vesting of Restricted Stock Units (RSUs). These transactions were conducted under a Rule 10b5-1 …

NTRA main company

Sharemaestro market context Trend signal active 52 weeks +87.2% · Next-week setup positive 57.5%

02:37 30 Jul 2026

Revelio Labs Earnings Main company 🇺🇸 United States

Danaher Number of Employees 2026 | Employee Count & Headcount Data

Danaher Corp. (DHR) had approximately 60,225 employees worldwide as of March 2026, representing a 0.8% decline from 2023. The company is actively hiring, with 6,341 active job postings in 2026, a 14.2% increase from 2025. Danaher's workforce is concentrated in the United States, India, …

DHR main company

Sharemaestro market context Price above Trend Line 52 weeks -3.7%

02:13 30 Jul 2026

TradingView Market update Provider-linked mention 🇺🇸 United States

LGHT ETF Holdings List — CBOE:LGHT

This article lists the top holdings of the Langar Global HealthTech ETF (LGHT) as of July 28, 2026. Key holdings include ResMed Inc., IQVIA Holdings Inc., and Intuitive Surgical, Inc., with their respective weight percentages, shares, and market values detailed. The ETF focuses on …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

02:11 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

LXRX|Lexicon Pharmaceuticals Inc|Price:2.385|Chg%:+0.065

Lexicon Pharmaceuticals Inc. (LXRX) shows relatively healthy fundamentals and high growth potential, with its valuation considered fairly priced within the Biotechnology & Medical Research industry. The company is actively developing several drug candidates, including pilavapadin for neuropathic pain and LX9851 for obesity, and is …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

02:10 30 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

MRKR|Marker Therapeutics Inc|Price:1.110|

This article provides a comprehensive stock analysis of Marker Therapeutics Inc (MRKR) by TradingKey, highlighting the company's strong fundamentals and significant growth potential despite a weak recent stock market performance. It notes a "Buy" consensus from multiple analysts with a higher price target, but …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

01:39 30 Jul 2026

TradingView Market update Main company 🇺🇸 United States

ETFs Investing in Adaptive Biotechnologies Corp. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Adaptive Biotechnologies Corp. (A2PLR5). It provides detailed financial data for each ETF, including market value, weight of Adaptive Biotechnologies stock, issuer, management style, focus, expense ratio, AUM, price change, and 3-year NAV …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

01:37 30 Jul 2026

Seeking Alpha Earnings Main company 🇺🇸 United States

IQVIA Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:IQV) 2026-07-28

IQVIA Holdings Inc. (NYSE:IQV) published its Q2 2026 earnings call presentation on July 28, 2026. The company reported an EPS of $3.15, beating estimates by $0.12, and revenue of $4.37 billion, surpassing expectations by $65.95 million with an 8.74% year-over-year increase. This article provides …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

00:41 30 Jul 2026

TradingView Analyst action Main company 🇺🇸 United States

NeoGenomics, Inc. Stock 12‑Month Price Target Raised to $19.72, Implies 47% Upside

Analyst estimates have led to an increased average 12-month price target for NeoGenomics, Inc. (NEO) stock, rising from $16.78 to $19.72, with a range of $16 to $35 per share. This updated target suggests a potential upside of approximately 47% from its closing price …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

00:40 30 Jul 2026

Moomoo Deals and strategy Main company 🇺🇸 United States

Fund Update: 1,098,204 ICON PLC (ICLR) Shares Added to GREENHAVEN ASSOCIATES INC Portfolio

GREENHAVEN ASSOCIATES INC has significantly increased its stake in ICON PLC (ICLR) by adding 1,098,204 shares to its portfolio, bringing its total holdings to 1,697,639 shares. This makes GREENHAVEN ASSOCIATES INC the 19th largest institutional investor in ICLR, with its investment now valued at …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

00:39 30 Jul 2026

TradingView Earnings Main company 🇺🇸 United States

GRAIL to Announce Second Quarter 2026 Financial Results

GRAIL, Inc. (Nasdaq: GRAL) announced it will release its second-quarter 2026 financial results after market close on Wednesday, August 5, 2026. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

00:06 30 Jul 2026

Sahm Earnings Main company 🇺🇸 United States

Agilent Technologies (A) Could Be 14% Undervalued Following FDA Cancer Test Approval

Agilent Technologies (A) stock is garnering attention after its PD-L1 IHC 28-8 pharmDx assay received FDA approval as a companion diagnostic for several gastrointestinal cancers. The company's share price saw positive returns recently, and a Simply Wall St analysis suggests the stock could be …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

00:00 30 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Adaptive Biotechnologies (ADPT) Reports Q2 Earnings: What Key Metrics Have to Say

Adaptive Biotechnologies (ADPT) reported $71.55 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 21.5%. EPS of -$0.10 for the same period compares to -$0.17 a year ago. The reported revenue represents a surprise of +7.98% over the Zacks …

ADPT main company

Sharemaestro market context Trend signal active 52 weeks +90.3% · Next-week setup positive 58.0%

23:42 29 Jul 2026

scanx.trade Earnings Main company 🇺🇸 United States

ICON plc Q2 Results: Revenue rises 1.2% YoY, adjusted EPS falls

ICON plc reported a 1.2% year-on-year revenue increase in Q2 2026, reaching $2,063.5 million, but saw its adjusted EPS decline to $2.56 due to restructuring and integration costs. Despite this, the company reaffirmed its full-year 2026 adjusted EPS guidance of $10.00-$11.00 and revenue guidance …

ICLR main company

Sharemaestro market context Trend signal active 52 weeks -7.2%

23:14 29 Jul 2026

Sharemaestro News Company research Main company 🇺🇸 United States

Labcorp’s 4.8M-share week puts the 52-week high back in reach as diagnostics breadth splits

LH rose 4.7% to $296.8, just 0.6% below its 52-week high, with volume at 1.5 times its 13-week average. The setup is constructive, but Sharemaestro reads it as balanced rather than decisive.

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%